A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies
Clinical trial NCT00651664 · COMPLETED
Trial details
- NCT number
- NCT00651664
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-22
- Primary completion
- 2010-09-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.